About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 3NCT03013517

Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children

This is an open-label, follow-up study for subjects who completed the PEPITES study. Subjects will be offered enrollment in this follow-up study to receive Viaskin Peanut 250 μg for 2 additional years...

Lead sponsor: DBV Technologies•17 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

DBV Technologies

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subjects who completed the PEPITES study.

Exclusion Criteria

•Generalized dermatologic disease (for example, active atopic dermatitis, uncontrolled generalized active eczema, ichthyosis vulgaris) extending widely on the skin and especially on the back or arms with no intact zones to apply the Viaskin patches.
•Diagnosis of asthma that evolved to severe, unstable or uncontrolled asthma.

Related studies

Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety

NCT06256146 · Peanut Allergy, Milk Allergy, Cow's, and more

RECRUITINGPhase 2

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

NCT03835767 · Milk and/or Peanut Allergy

RECRUITINGPhase 2

Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

NCT05695261 · Allergy, Peanut, Peanut Allergy, and more

Enrolling By InvitationPhase 2

Food Oral Immunotherapy for Peanut Allergy

NCT04222491 · Peanut Allergy

Active Not RecruitingNA

Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT

NCT04511494 · Peanut Allergy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 2, 2020Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE3

Enrollment300

Start dateJan 2017

Last updatedDec 2, 2020

Condition

Locations shown

Arkansas Children's Hospital

Little Rock, Arkansas

University of California, Rady Children's Hospital

San Diego, California

Stanford University School of Medicine

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 2, 2020Data synced to Clareo: May 16, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions